| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/OFID/OFW143 |
| P8608 | Fatcat ID | release_le72k3op6fhpdf7m6gsjxdutbm |
| P932 | PMC publication ID | 5047423 |
| P698 | PubMed publication ID | 27704002 |
| P50 | author | Hiroshige Mikamo | Q115116073 |
| Naomi Sugimoto | Q124812170 | ||
| P2093 | author name string | Akira Yuasa | |
| Bruce Crawford | |||
| Keiko Wada | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America | Q28268745 | ||
| Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study | Q28535024 | ||
| Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections. | Q34057425 | ||
| Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention | Q34190800 | ||
| Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). | Q35545954 | ||
| Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials | Q36561300 | ||
| Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial. | Q38474221 | ||
| A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. | Q40644155 | ||
| Randomized study of minocycline + gentamicin compared with metronidazole + gentamicin for prophylaxis or treatment of mixed infections in abdominal surgery | Q40811527 | ||
| Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan | Q41639187 | ||
| In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria | Q42110245 | ||
| Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial | Q42275878 | ||
| A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections | Q42952452 | ||
| Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections | Q44136341 | ||
| Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults | Q44183675 | ||
| Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections | Q44404714 | ||
| Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group | Q44625981 | ||
| Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement | Q44746826 | ||
| Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections | Q45044314 | ||
| Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. | Q45074770 | ||
| A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections | Q45286739 | ||
| Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections. | Q53979811 | ||
| Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group | Q71654604 | ||
| Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections | Q73287044 | ||
| Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections | Q79787617 | ||
| A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections | Q80470551 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | metronidazole | Q169569 |
| antibiotic resistance | Q380775 | ||
| P304 | page(s) | ofw143 | |
| P577 | publication date | 2016-07-07 | |
| P1433 | published in | Open Forum Infectious Diseases | Q27725953 |
| P1476 | title | Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole | |
| P478 | volume | 3 |
| Q60310408 | A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China | cites work | P2860 |
Search more.